Pfizer – Withdrawal of Oxbryta® (voxelotor) tablets
September 25, 2024 - Pfizer announced a voluntary withdrawal of all lots of Oxbryta (voxelotor) tablets because the overall benefit of Oxbryta no longer outweighs the risk in the approved sickle cell patient population.